The increasing recognition of Epstein–Barr virus (EBV) as a major contributor to infectious mononucleosis, several malignancies, autoimmune disorders, and other immune-mediated conditions is creating significant opportunities across the healthcare sector. The mononucleosis diagnostic market is attracting growing attention as clinicians seek dependable methods to distinguish EBV infection...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek